PDAC - Pancreatic Ductal Adenocarcinoma research hub
3 indexed studies · 3 currently recruiting
- recruiting
Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma
Researchers are developing a breath test for pancreatic cancer. This test looks for tiny chemicals in your breath that might change when pancreatic cancer is present. The goal is to help doctors find pancreatic cancer earlier, especially in people with unclear symptoms, so treatment can start sooner.
United Kingdom - recruiting
Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2)
We're testing a new breath test to find pancreatic cancer earlier. This is important because pancreatic cancer can be hard to spot early. The test looks for special smells on your breath that might be linked to the cancer. Finding it sooner could mean more treatment choices and better health outcomes.
United Kingdom - recruitingPHASE3
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
This study is for people who have had surgery for pancreatic cancer. We are testing a new drug, daraxonrasib, to see if it can stop the cancer from coming back, compared to just being watched. It's to help see if this new treatment works better.
United States · Puerto Rico · United Kingdom